西安高级鼻咽拭子训练模型(十堰男性生殖器层次解剖模型) (今日更新中)

The service academy game between Air Force and Army scheduled for Saturday at West Point, New York, was postponed Thursday due to an increase in COVID-19 cases at the Air Force Academy and the surrounding community."We are disappointed to postpone this game, but the health and safety of our cadets, staff, and the community continues to be our No. 1 priority at the Academy," Air Force Falcons Director of Athletics Nathan Pine said in a press release. "Due to the upward trends in our COVID numbers across the campus, we have paused all intercollegiate team activities."The Falcons can win the Commander-in-Chief’s Trophy with a win over Army. Air Force began the round-robin competition between the service academies with a 40-7 win over Navy on Oct. 3.The winning academy goes to the White House to receive the coveted trophy from the President.According to The Athletic's Stewart Mandel, this marks the seventh college football game this week to be postponed or canceled due to COVID.The schools are working to reschedule the game. 1044

The U.S. House of Representatives voted in a bipartisan manner to remove statues honoring Confederate leaders from the Capitol. The bill was approved by a 305-113 vote on Wednesday, with 72 Republicans joining Democrats in support of the bill.The bill also would remove the bust of Roger Brooke Taney and replace it with Thurgood Marshall’s bust. Taney’s bust is located in the Old Supreme Court Chamber inside the Capitol complex.Taney infamous;y ruled in 1857 that Blacks could not be full US citizens in the Dred Scott v Sandford case. Taney wrote the Supreme Court opinion which upheld slavery in the United States.Previously, House Speaker Nancy Pelosi targeted 11 statues for removal.The statues are held in Statuary Hall, and is a prominent spot for visitors of the US Capitol. The hall is frequently seen in the background of media interviews with members of Congress.Each state sends two statues to be viewed in Statuary Hall. States largely decide on the statues to be displayed in the hall. Among the statues in Statuary Hall include Confederacy president Jefferson Davis and Confederate commander Robert E. Lee.Democratic Rep. Steny Hoyer of Maryland sponsored the bill.“I believe that most Americans are deeply distressed by racial injustice and want to see the progress of the Civil Rights Movement continue,” Hoyer said. They want our nation and our democracy to grow, mature, and become more perfect. Part of that process is making it clear, through our symbols and public displays of honor, what our country stands for and, as importantly, what it must never stand for again."Republican Paul Mitchell, R-Mich., joined Hoyer in calling for the removal of the statues.“The history of this nation is so fraught with racial division, with hatred, and the only way to overcome that is to recognize that, acknowledge it for what it is. So I support this resolution,” Mitchell said.Mitchell added that the statues should be returned to the states and be used for appropriate historical context.“Tearing it down does not do justice for the history of this nation and what our young people must understand,” Mitchell added.Whether the bill gets heard in the Senate remains doubtful, as Senate Majority Leader Mitch McConnell said last month the removal of the statues is a “bridge too far.” 2306

The US Centers for Disease Control and Prevention warned US consumers on Tuesday to not eat romaine lettuce, as it may be contaminated with E. coli.Thirty-two people, including 13 who have been hospitalized, have been infected with the outbreak strain in 11 states, according to the CDC. One of the hospitalized people developed hemolytic uremic syndrome, a potentially life-threatening form of kidney failure. No deaths have been reported.People have become sick in California, Connecticut, Illinois, Massachusetts, Maryland, Michigan, New Hampshire, New Jersey, New York, Ohio and Wisconsin.The Public Health Agency of Canada has identified an additional 18 people who have become sick with the same strain of of E. coli in Ontario and Quebec.If you have any romaine lettuce at home, you should throw it away, even if you have eaten some and did not get sick, the CDC cautioned."This advice includes all types or uses of romaine lettuce, such as whole heads of romaine, hearts of romaine, and bags and boxes of precut lettuce and salad mixes that contain romaine, including baby romaine, spring mix, and Caesar salad," the CDC said in its announcement.All types and brands of romaine lettuce are suspect because no common grower, supplier, distributor or source company has been identified by the CDC.Retailers and restaurants also should not serve or sell any until more is known about the outbreak.Symptoms of E. coli infection, which usually begin about three or four days after consuming the bacteria, can include watery or bloody diarrhea, fever, abdominal cramps, nausea and vomiting, according to the CDC. Most people infected by the bacteria get better within five to seven days, though this particular strain of E. coli tends to cause more severe illness.People of all ages are at risk of becoming infected with Shiga toxin-producing E. coli, according to the US Food and Drug Administration, which is also investigating the outbreak. Children under 5, adults older than 65 and people with weakened immune systems, such as people with chronic diseases, are more likely to develop severe illness, but even healthy children and adults can become seriously ill.Illnesses started in October. This outbreak is not related to a multistate outbreak linked to romaine lettuce this summer.The-CNN-Wire 2311

The U.S. regulators who will decide the fate of COVID-19 vaccines are taking an unusual step: Asking outside scientists if their standards are high enough.The Food and Drug Administration may have to decide by year’s end whether to allow use of the first vaccines against the virus. Thursday, a federal advisory committee pulls back the curtain on that decision process, debating whether the guidelines FDA has set for vaccine developers are rigorous enough.“We will not cut corners, and we will only use science and data to make that determination,” FDA Commissioner Stephen Hahn pledged at a meeting of the Milken Institute Wednesday.Exactly how much data his agency needs to be sure a vaccine is safe and effective is a key question for the advisers. An even bigger one: If the FDA allows emergency use of a vaccine before final testing is finished, will that destroy chances of ever learning just how well that shot -- and maybe competitors still being studied -- really work?“We can’t lose sight of the fact that it is in our societal interest to see these trials to completion,” said Dr. Luciana Borio, a former FDA acting chief scientist who will be watching the advisers’ debate.Plus, multiple vaccines are being studied -- shots made with different technologies that each have pros and cons.“The first vaccine is not necessarily the best vaccine,” cautioned Dr. M. Miles Braun, a former FDA scientist now with Georgetown University School of Medicine. If the trials aren’t allowed to finish, it may be difficult or impossible to ever know for sure.It’s a critical moment in FDA’s 114-year history. The government has spent billions to race a vaccine through a research process that usually takes years, and FDA faces unprecedented pressure from the Trump administration, fueling public skepticism that politics could overrule science.Interest is so high, FDA is airing the meeting on YouTube. Here are some key issues the committee will discuss:HOW MUCH EVIDENCE IS NEEDED?FDA is requiring manufacturers to do studies of at least 30,000 people to prove if a vaccine protects and how safe it is. Those studies must include adequate numbers of people at highest risk from COVID-19 -- older adults, minorities and anyone with underlying health problems.FDA has made clear that any vaccine must be at least 50% effective. And while the studies are designed to run for two years, companies may get enough evidence the shots are protective -- in at least some people -- to stop the trials early and seek what’s called an “emergency use authorization” for wider vaccinations.Despite White House objections, the FDA told vaccine makers earlier this month not to seek that speedier review until they’ve tracked at least half their trial participants for two months. With other vaccines, that’s about the amount of time when major side effects crop up.That’s not long enough, said the head of the non-profit ECRI Institute, which reviews medical technology for hospitals and insurers. In comments submitted to the advisory committee, ECRI’s Dr. Marcus Schabacker said FDA should require six months of follow-up.“Doing any less would simply risk too much, and the consequences may be severe,” he wrote. “A weak vaccine that loses public trust could poison the well for epidemic control for many years.”WOULD EMERGENCY USE DERAIL FULL ANSWERS ABOUT VACCINES?Normally when a study ends because of evidence that a vaccine is working, the participants who got dummy shots are offered the real thing.But if FDA allows emergency use of a COVID-19 vaccine, that’s not the same as having full proof the shot works, Borio cautioned.And if the participants in the placebo group are immediately offered the real shot, researchers may not be able to get answers about all the high-risk groups in the study — or tell how long the vaccine’s protection lasts, a process expected to take many more months.But Pfizer Inc., which with Germany’s BioNTech is developing one of the leading candidates, told FDA that if it’s granted emergency use authorization, it “would have an ethical obligation” to alert study participants who got a placebo and allow them vaccine access. The company wants FDA to look into “other scientifically and statistically sound methods” to determine long-term safety and effectiveness.Pfizer’s stance is likely to face pushback. The Infectious Diseases Society of America states that FDA’s panelists “should insist” that vaccine developers “present a compelling case” for how they will complete their trials if FDA grants early authorization of their vaccine.Clearing a vaccine based on premature or faulty data “could cause more harm” by “further eroding public confidence in all vaccines,” the group said.It’s an unprecedented dilemma. The FDA has previously allowed emergency use of only one vaccine, a decades-old shot that in 2005 was authorized to prevent anthrax poisoning.This time around, multiple COVID-19 vaccines are in the pipeline. Pfizer competitor Johnson & Johnson cautioned that early FDA clearance of one vaccine could “jeopardize integrity” of other ongoing trials if patients decide to drop out to seek the first cleared shot instead.The company asked regulators to explain what options are available to ensure completion of all ongoing COVID-19 vaccine trials.WHAT ABOUT LONG-TERM SAFETY MONITORING?Even a study of 30,000 people cannot spot a side effect that only strikes 1 in 100,000. So the government is planning extra scrutiny of every COVID-19 vaccine to hit the market.At first there will be limited doses given to just certain high-risk people -- and those early recipients are to get text messages daily for the first week after vaccination, and then weekly out to six weeks, asking how they’re feeling.FDA also will be checking databases of electronic health records and insurance claims, looking for any red flags.“There’s a kind of tracking that has to take place here on a massive basis that hasn’t taken place before,” said Dr. Jesse Goodman of Georgetown University, a former director of the FDA’s vaccine and biologics center.___The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. 6274

The stairs in the entrance of the house used as the home of psychotic killer Buffalo Bill in the 1991 film "The Silence of the Lambs" is seen for sale on Monday, Jan. 11, 2016 in Perryopolis, Pa. Scott and Barbara Lloyd listed the house last summer, but they've dropped the asking price from 0,000 to 0,000. 321

来源：资阳报